Codexis, Inc. (CDXS)

NMS – Real vaqt narxi. Valyuta: USD

1.60

+0.12 (8.11%)

Yopilishda: Aug 12, 2026, 4:00 PM EDT

1.60

0.00 (0.00%)

Bozordan keyin: Aug 12, 2026, 4:01 PM EDT

12.08.2026

Codexis, Inc. (CDXS) Q2 2026 Earnings Call Transcript

11.08.2026

Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates

Codexis (CDXS) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.16 per share a year ago.

11.08.2026

Codexis Q2 Earnings Call Highlights

Codexis NASDAQ: CDXS reported second-quarter 2026 revenue of $14.9 million, compared with $15.3 million in the prior-year period, as the company highlighted improved performance in its biocatalytic enzyme business and continued development of its ECO Synthesis platform for siRNA manufacturing.

11.08.2026

Codexis Reports Second Quarter 2026 Financial Results

Reports revenue of $14.9 million for the second quarter of 2026, company reiterates full-year financial guidance Shared new advances in RNA therapeutic manufacturing at TIDES US showing that its ECO Synthesis® Manufacturing Platform exerts enzyme-driven stereoisomer control of siRNA Completed successful equity capital raise of approximately $25 million in net proceeds REDWOOD CITY, Calif., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced financial results for the second quarter ended June 30, 2026, and provided a business update.

03.08.2026

Codexis Appoints David Butler, PhD, to Strategic Advisory Board

REDWOOD CITY, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex oligonucleotide therapeutics, today announced the appointment of David Butler, PhD, to its Strategic Advisory Board (SAB).

Videolar

No Data

There is no data to display

Press-relizlar

11.08.2026

Codexis Reports Second Quarter 2026 Financial Results

03.08.2026

Codexis, Inc. (CDXS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Codexis, Inc. (CDXS)

Codexis, Inc. (CDXS) Q2 2026 Earnings Call Transcript

Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates

Codexis Q2 Earnings Call Highlights

Codexis Reports Second Quarter 2026 Financial Results

Codexis Appoints David Butler, PhD, to Strategic Advisory Board

Videolar

No Data

Press-relizlar

Codexis Reports Second Quarter 2026 Financial Results

Codexis Appoints David Butler, PhD, to Strategic Advisory Board

Codexis, Inc. (CDXS) Q2 2026 Earnings Call Transcript

Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates

Codexis Q2 Earnings Call Highlights

Codexis Reports Second Quarter 2026 Financial Results

Codexis Appoints David Butler, PhD, to Strategic Advisory Board

Videolar

No Data

Press-relizlar

Codexis Reports Second Quarter 2026 Financial Results

Codexis Appoints David Butler, PhD, to Strategic Advisory Board

Search stocks

Codexis, Inc. (CDXS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Codexis, Inc. (CDXS)

Codexis, Inc. (CDXS) Q2 2026 Earnings Call Transcript

Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates

Codexis Q2 Earnings Call Highlights

Codexis Reports Second Quarter 2026 Financial Results

Codexis Appoints David Butler, PhD, to Strategic Advisory Board

Videolar

No Data

Press-relizlar

Codexis Reports Second Quarter 2026 Financial Results

Codexis Appoints David Butler, PhD, to Strategic Advisory Board

Codexis, Inc. (CDXS) Q2 2026 Earnings Call Transcript

Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates

Codexis Q2 Earnings Call Highlights

Codexis Reports Second Quarter 2026 Financial Results

Codexis Appoints David Butler, PhD, to Strategic Advisory Board

Videolar

No Data

Press-relizlar

Codexis Reports Second Quarter 2026 Financial Results

Codexis Appoints David Butler, PhD, to Strategic Advisory Board